MONOGRAPHS (USP) Saccharin Sodium

Similar documents
MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

BRIEFING Assay + + +

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

Change to read: BRIEFING

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

BRIEFING. 1. Definition Changed to include only Wheat Starch, as to conform to the individual monograph for Wheat Starch.

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

BRIEFING. Nonharmonized attributes: Characters, Microbial Enumeration Tests, and Tests for Specified Microorganisms, and Packing and Storage (USP)

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

E17 ETHYLCELLULOSE. Revision 3 Stage 4

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

6.02 Uniformity of Dosage Units

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Draft proposal for The International Pharmacopoeia

Heparin Sodium ヘパリンナトリウム

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Lutein Esters from Tagetes Erecta

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

Title Revision n date

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

THERMALLY OXIDIZED SOYA BEAN OIL

Hydroxypropyl Starch (Tentative)

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Purity Tests for Modified Starches

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

GB Translated English of Chinese Standard: GB NATIONAL STANDARD

COMMENTARY TO USP31 - NF26

EMTRICITABINE AND TENOFOVIR TABLETS

INTERIM REVISION ANNOUNCEMENT

SWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

E55A GELATIN, GELLING GRADE Gelatina

IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

Student Practical Guide (1) Milk of Magnesia

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Revision Bulletin 28 Jul Aug 2017 Chemical Medicines Monographs 3

Draft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

Final text for addition to The International Pharmacopoeia (June 2010)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN THE FOURTH EDITION OF The International Pharmacopoeia

PHCH 402: Analytical Quality Control Different methods of analysis of some groups of drugs in common use in Nigeria (8 hrs)

INTERNATIONAL ŒNOLOGICAL CODEX. BENTONITES Bentonita N SIN: 558 (Oeno 11/2003 modified Oeno )

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Official Journal of the European Union REGULATIONS

Nitrate and Nitrite Key Words: 1. Introduction 1.1. Nature, Mechanism of Action, and Biological Effects (Fig. 1)

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

Feedstuffs Analysis G-22-1 PROTEIN

EUDRAGIT L 100 and EUDRAGIT S 100

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

Diltiazem Hydrochloride Extended-Release Capsules. Type of Posting Posting Date Official Date

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

CLINDAMYCIN PALMITATE

THE ESTIMATION OF TRYPSIN WITH HEMOGLOBIN

VOLUNTARY MONOGRAPH. Council for Responsible Nutrition March 2006

Revision Bulletin 23 Feb Mar 2018 Chemical Medicines Monographs 3 Compliance

Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives

By Authority Of THE UNITED STATES OF AMERICA Legally Binding Document

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

DRAFT EAST AFRICAN STANDARD

L 346/6 Official Journal of the European Union

3016 Oxidation of ricinoleic acid (from castor oil) with KMnO 4 to azelaic acid

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Instruction Manual Updated 8/27/2013 Ver. 1.1

Corn Starch Analysis B-47-1 PHOSPHORUS

Telmisartan and Hydrochlorothiazide Tablets. Type of Posting. Revision Bulletin Posting Date. 26 Jan 2018 Official Date

Transcription:

Vol. 31(4) [July Aug. 2005] HARMONIZATION 1225 MONOGRAPHS (USP) BRIEFING Saccharin Sodium, USP 28 page 1745 and page 612 of PF 31(2) [Mar. Apr. 2005]. The United States Pharmacopeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Saccharin Sodium monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the ADOPTION STAGE 6 document, is based in part on comments from the Japanese Pharmacopoeia and the European Pharmacopoeia in response to the Provisional Harmonized Text Stage 5A and 5B drafts prepared by the United States Pharmacopeia. Pharmacopeial Discussion Group Sign-Off Document Attributes EP JP USP Definition + + + Identification B + + + Identification C + + Acidity or alkalinity + + + Water + + + Readily carbonizable substances + + + Limit of benzoate and salicylate + + Assay + + + Legend: + will adopt and implement; will not stipulate. Nonharmonized attributes: Packaging and storage, Heavy metals, Labeling, Clarity of solution, Color of solution, Limit of toluenesulfonamides, Identification A (IR). Specific local attributes: USP: Organic volatile impurities; JP: Description. Reagents and reference materials: Each pharmacopeia will adapt the text to take account of local reference materials and reagent specifications. Differences between the ADOPTION STAGE 6 document and the current NF monograph include the following: (1) In the opening paragraph (the Definition) The lower limit is changed from not less than 98.0 percent to not less than 99.0 percent. (2) Packaging and storage Storage conditions at room temperature are added. (3) Labeling No change. (4) USP Reference standards A reference for Saccharin Sodium is added for use in the Identification test A. (5) Clarity of solution ThistestisaddedtocomplywithEP standards. (6) Color of solution This test is added to comply with EP standards. (7) Identification Identification tests A, B, and D are replaced with a more definitive IR absorption test. Identification test C is retained, but separated into two tests (B and C). Because the preparation of potassium pyroantimonate TS has changed, the preparation of the potassium pyroantimonate solution for this test is added to comply with the harmonization draft. (8) Water No change. (9) Readily carbonizable substances No change. (10) Selenium This test is deleted because it is unnecessary for this compound. (11) Limit of toluenesulfonamides The test method and limits are changed to those of the European Pharmacopoeia, which include a more modern test method. The Test solution is corrected to that of the EP. Editorial changes are made. (12) Heavy metals No change. (13) Limit of benzoate and salicylate No change. (14) Organic volatile impurities No change. (15) Assay No change. (EMC: J. Lane) Change to read: RTS 42529-1 Saccharin Sodium C 7 H 4 NNaO 3 S 2H 2 O 241.20 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, dihydrate. 1,2-Benzisothiazolin-3-one 1,1-dioxide sodium salt dihydrate [6155-57-3]. Anhydrous 205.17 [128-44-9].» Saccharin Sodium contains not less than 98.0 percent and not more than 101.0 percent of C 7 H 4 NNaO 3 S, calculated on the anhydrous basis. Packaging and storage Preserve in well-closed containers. Labeling Where the quantity of saccharin sodium is indicated in the labeling of any preparation containing Saccharin Sodium, this shall be expressed in terms of saccharin (C 7 H 5 NO 3 S). USP Reference standards h11i USP o-toluenesulfonamide RS. USP p-toluenesulfonamide RS. Identification A: The residue obtained by igniting it responds to the tests for Sodium h191i. B: To 10 ml of a solution (1 in 10) add 1 ml of hydrochloric acid: a crystalline precipitate of saccharin is formed. Wash the precipitate with cold water until the last washing is free from chloride, and dry at 1058 for 2 hours: it melts between 2268 and 2308, the procedure for Class I being used (see Melting Range or Temperature h741i). Alkalinity A solution (1 in 10) is neutral or alkaline to litmus, but no red color is produced with phenolphthalein TS.

1226 HARMONIZATION Vol. 31(4) [July Aug. 2005] Toluenesulfonamides Internal standard solution,standard stock solution, and Standard preparations Prepare as directed for Internal standard solution, Standard stock solution, and Standard preparations in the test for Toluenesulfonamides under Saccharin (see NF monograph). Test preparation Prepare as directed under Column Partition Chromatography (see Chromatography h621i), employing a chromatographic tube fitted with a porous glass disk in its base, a plastic stopcock on the delivery tube, and a reservoir on the top. Add a mixture consisting of 10 g of Solid Support and a solution of 2.0 g, accurately weighed, of Saccharin Sodium in 8.0 ml of sodium carbonate solution (1 in 20), and proceed as directed under Test preparation in the test for Toluenesulfonamides under Saccharin (see NF monograph), beginning with Pack the contents. Chromatographic system and Procedure Proceed as directed for Chromatographic system and Procedure in the test for Toluenesulfonamide under Saccharin (see NF monograph). Heavy metals, Method I h231i Dissolve 4 g in 46 ml of water, add 4 ml of 1 N hydrochloric acid, mix, and rub the inner wall of the vessel with a glass rod until crystallization begins. Allow the solution to stand for 1 hour, and then filter through a dry filter, discarding the first 10 ml of the filtrate: the limit, determined on 25 ml of the subsequent filtrate, is 0.001%. Organic volatile impurities, Method IV h467i: meets the requirements. Other requirements It responds to Identification tests A and B, and meets the requirements of the tests for Water, Benzoate and salicylate, Selenium, and Readily carbonizable substances under Saccharin Calcium. Assay Proceed with Saccharin Sodium as directed in the Assay under Saccharin Calcium. Each ml of 0.1 N sodium hydroxide is equivalent to 20.52 mg of C 7 H 4 NNaO 3 S. &Saccharin Sodium C 7 H 4 NNaO 3 S 2H 2 O 241.20 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, dihydrate. 1,2-Benzisothiazolin-3-one 1,1-dioxide sodium salt dihydrate [6155-57-3]. Anhydrous 205.17 [128-44-9].» Saccharin Sodium contains not less than 99.0 percent and not more than 101.0 percent of C 7 H 4 NNaO 3 S 2H 2 O, calculated on the anhydrous basis. Packaging and storage Preserve in well-closed containers. Store at room temperature. Store at room temperature. Labeling Where the quantity of saccharin sodium is indicated in the labeling of any preparation containing Saccharin Sodium, this shall be expressed in terms of saccharin (C 7 H 5 NO 3 S). USP Reference standards h11i USP Saccharin Sodium RS. USP o-toluenesulfonamide RS. USP p-toluenesulfonamide RS. Clarity of solution [NOTE The Test solution is to be compared to Reference suspension A andtowaterindiffused daylight 5 minutes after preparation of Reference suspension A.] Hydrazine solution Transfer 1.0 g of hydrazine sulfate to a 100-mL volumetric flask, dissolve in and dilute with water to volume, and mix. Allow to stand for 4 to 6 hours. Methenamine solution Transfer 2.5 g of methenamine to a 100-mL glass-stoppered flask, add 25.0 ml of water, insert the glass stopper, and mix to dissolve. Primary opalescent suspension [NOTE This suspension is stable for 2 months, provided it is stored in a glass container free from surface defects. The suspension must not adhere to the glass and must be well mixed before use.] Transfer 25.0 ml of Hydrazine solution to the Methenamine solution in the 100-mL glass-stoppered flask. Mix, and allow to stand for 24 hours.

Vol. 31(4) [July Aug. 2005] HARMONIZATION 1227 Opalescence standard [NOTE This suspension should not be used beyond 24 hours after preparation.] Transfer 15.0 ml of the Primary opalescent suspension to a 1000- ml volumetric flask, dilute with water to volume, and mix. Reference suspensions Transfer 5.0 ml of the Opalescence standard to a 100-mL volumetric flask, dilute with water to volume, and mix to obtain Reference suspension A. Transfer 10.0 ml of the Opalescence standard to a second 100-mL volumetric flask, dilute with water to volume, and mix to obtain Reference suspension B. Test solution Dissolve 5.0 g of test material in about 20 ml of a 200 g per L solution of sodium acetate, dilute with water the same solution to 25 ml, and mix. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 mm to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Reference suspension A, Reference suspension B, water, and a 200 g per L solution of sodium acetate to separate matching test tubes. Compare the Test solution, Reference suspension A, Reference suspension B, water, and a 200 g per L solution of sodium acetate in diffused daylight, viewing vertically against a black background (see Visual Comparison under Spectrophotometry and Light-Scattering h851i). [NOTE The diffusion of light must be such that Reference suspension A can readily be distinguished from water, and that Reference suspension B can readily be distinguished from Reference suspension A.] The Test solution shows the same clarity as that of water, or of the 200 g per L solution of sodium acetate, or its opalescence is not more pronounced than that of Reference suspension A. Color of solution Standard stock solution Combine 3.0 ml of ferric chloride CS, 3.0 ml of cobaltous chloride CS, 2.4 ml of cupric sulfate CS, and 1.6 ml of dilute hydrochloric acid (10 g per L). Standard solution [NOTE Prepare the Standard solution immediately before use.] Transfer 1.0 ml of Standard stock solution to a 100-mL volumetric flask, dilute with dilute hydrochloric acid (10 g per L) to volume, and mix. Test solution Use the Test solution from the test for Clarity of solution. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 mm to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Standard solution, a 200 g per L solution of sodium acetate, and water to separate matching test tubes. Compare the Test solution, the Standard solution, a 200 g per L solution of sodium acetate, and water in diffused daylight, viewing vertically against a white background (see Visual Comparison under Spectrophotometry and Light-Scattering h851i). The Test solution has the appearance of water or of the 200 g per L solution of sodium acetate, or is not more intensely colored than the Standard solution. Identification A: Infrared Absorption h197ki Dry the specimen at 1058 for 2 hours before use. B: To a solution (1 in 10) add 2 ml of 15% potassium carbonate, and heat to boiling. No precipitate is formed. Add 4 ml of potassium pyroantimonate TS Potassium pyroantimonate solution, and heat to boiling. Allow to cool in ice water and, if necessary, rub the inside of the test tube with a glass rod. A dense precipitate is formed.

1228 HARMONIZATION Vol. 31(4) [July Aug. 2005] Potassium pyroantimonate solution Dissolve 2 g of potassium pyroantimonate in 95 ml of hot water. Cool quickly, and add a solution containing 2.5 g of potassium hydroxide in 50 ml of water and 1 ml of sodium hydroxide solution (8.5 in 100). Allow to stand for 24 hours, filter, and dilute with water to 150 ml. C: Sodium salts impart an intense yellow color to a nonluminous flame. Acidity or alkalinity To a solution of 1.0 g in 10 ml of carbon dioxide-free water add 1 drop of phenolphthalein TS:nopinkcolorisproduced.Thenadd1dropof0.1N sodium hydroxide: a pink color is produced. Water, Method I h921i: not more than 15.0%. Readily carbonizable substances h271i Dissolve 200 mg in 5 ml of sulfuric acid (between 94.5% and 95.5% [w/w] of H 2 SO 4 ), and keep at a temperature of 488 to 508 for 10 minutes: the solution has no more color than Matching Fluid A, when viewed against a white background. Heavy metals, Method I h231i Dissolve 4 g in 46 ml of water, add 4 ml of dilute hydrochloric acid (1 in 12), mix, and rub the inner wall of the vessel with a glass rod until crystallization begins. Allow the solution to stand for 1 hour, then pass through a dry filter, discarding the first 10 ml of the filtrate, and use 25 ml of the subsequent filtrate for the Test Preparation: the limit is 0.001%. Limit of toluenesulfonamides Internal standard solution Dissolve 25 mg of caffeine in methylene chloride, and dilute with the same solvent to 100 ml. Reference solution Dissolve 20.0 mg of USP o-toluenesulfonamide RS and 20.0 mg of USP p-toluenesulfonamide RS in methylene chloride, and dilute with the same solvent to 100.0 ml. Dilute 5.0 ml of the solution with methylene chloride to 50.0 ml. Evaporate 5.0 ml of the final solution to dryness in a stream of nitrogen. Dissolve the residue in 1.0 ml of the Internal standard solution. Test solution Suspend 10.0 g of the substance to be examined in 20 ml of water, and dissolve using 5 ml to 6 ml of 1 10 N sodium hydroxide. Dissolve 10.0 g of the substance to be examined in about 45 ml of water. If necessary, adjust the solution with 1 N sodium hydroxide or 1 N hydrochloric acid to a ph of 7 to 8, and dilute with water to 50 ml. Shake the solution with four quantities each of 50 ml of methylene chloride. Combine the lower layers, dry over anhydrous sodium sulfate, and filter. Wash the filter and the sodium sulfate with 10 ml of methylene chloride. Combine the solution and the washings, and evaporate almost to dryness in a water bath at a temperature not exceeding 408. Using a small quantity of methylene chloride, quantitatively transfer the residue into a suitable 10-mL tube, evaporate to dryness in a stream of nitrogen, and dissolve the residue in 1.0 ml of the Internal standard solution. Blank solution Evaporate 200 ml of methylene chloride to dryness in a water bath at a temperature not exceeding 408. Dissolve the residue in 1 ml of methylene chloride. Chromatographic system (see Chromatography h621i) The instrument gas chromatograph is equipped with a flame-ionization detector and contains a 0.53-mm 6 10-m fused silica column, coated with G3 phase (film thickness 2 mm). The injector port, column, and detector temperatures are maintained at about 2508, 1808, and 2508, respectively; and nitrogen is used as the carrier gas at a flow rate of about 10 ml per minute. The injector employs a split ratio of 1 : 2. Procedure Inject about 1 ml of the Reference solution. Adjust the sensitivity of the detector so that the height of the peak due to caffeine is not less than 50% of the full scale of

Vol. 31(4) [July Aug. 2005] HARMONIZATION 1229 the recorder. The substances are eluted in the following order: o-toluenesulfonamide, p-toluenesulfonamide, and caffeine. The test is not valid unless the resolution between the peaks due to o-toluenesulfonamide and p-toluenesulfonamide is at least 1.5. Inject about 1 ml of the Blank solution. In the chromatogram obtained, verify that there are no peaks with the same retention times as the internal standard, o-toluenesulfonamide, and p-toluenesulfonamide. Inject about 1 ml of the Test solution and 1 ml of the Reference solution. If any peaks due to o-toluenesulfonamide and p-toluenesulfonamide appear in the chromatogram obtained with the Test solution, the ratio of their areas to that of the internal standard is not greater than the corresponding ratio in the chromatogram obtained with the Reference solution (10 ppm of o-toluenesulfonamide and 10 ppm of p-toluenesulfonamide). Limit of benzoate and salicylate To 10 ml of a solution (1 in 20), previously acidified with 5 drops of 6 N acetic acid, add 3 drops of ferric chloride TS: no precipitate or violet color appears. Organic volatile impurities, Method I h467i: meets the requirements. Assay Dissolve, with the aid of slight heating if necessary, about 150 mg of Saccharin Sodium, accurately weighed, in 50 ml of glacial acetic acid. Titrate with 0.1 N perchloric acid, determining the endpoint potentiometrically. Perform a blank titration, if necessary, and make the appropriate correction. Each ml of 0.1 N perchloric acid is equivalent to 20.52 mg of C 7 H 4 NNaO 3 S. &2S (USP29) MONOGRAPHS (NF) BRIEFING Silicon Dioxide, NF 23 page 3073 and page 7187 of PF 24(6) [Nov. Dec. 1998]. The Japanese Pharmacopoeia is the coordinating pharmacopoeia for the international harmonization of the compendial standards for the Silicon Dioxide monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the Revised OFFICIAL INQUIRY STAGE 4 document, is based in part on comments from the Japanese Pharmacopoeia and the European Pharmacopoeia in response to the Provisional Harmonized Text Stage 4 draft prepared by the Japanese Pharmacopoeia. Differences between the Revised OFFICIAL INQUIRY STAGE 4 document and the current NF monograph include the following: (1) In the opening paragraph (the Definition) The Definition is modified to include the term, "separating," to allow for the two processes of manufacturing, gel and precipitate. An upper limit for Assay is added. The current EP lower limit of 98.0% is adopted. (2) Packaging and storage No change. The USP text is retained as a nonharmonized attribute. (3) Labeling The requirement to label the different types of silica are omitted, because the Definition is changed. A requirement to label with the bulk density is added. (4) Identification Two additional identification procedures are added to strengthen the monograph. (5) ph The limit is unchanged, but the slurry concentration is slightly less. (6) Loss on drying The drying time and temperature are changed to 2 hours and 1058, respectively, and the limit is increased to 7.0%, as related to the time and temperature change. (7) Loss on ignition The ignition time is increased from 1 hour to 2 hours. (8) Heavy metals The USP test is retained as a nonharmonized attribute. (9) Chloride The test is omitted, because it is not necessary. (10) Hydrochloric acid soluble substances This test is added to indirectly control levels of aluminum and calcium. (11) Sulfate The JP test is adopted and the limit is increased to 1.0%. (12) Organic volatile impurities This test is retained as a specific local attribute for USP. (13) Arsenic This test is retained as a nonharmonized attribute. (14) Iron This test is added to limit iron impurities.